Skip to main content
logo
IQVIA Holdings Inc. (IQV)
NYSE: IQV · Real-Time Price · USD
207.32
+8.80 (4.43%)
Jul 23, 2026, 4:00 PM EDT - Market closed

Revenue Breakdown 2

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
Technology & Analytics Solutions Revenue
-6.63B6.16B
Technology & Analytics Solutions Revenue Growth
-7.56%5.08%
Research & Development Solutions Revenue (Pre-FY2026)
-8.90B8.53B
Research & Development Solutions Revenue (Pre-FY2026) Growth
-4.33%1.57%
Contract Sales & Medical Solutions Revenue
-788.00M718.00M
Contract Sales & Medical Solutions Revenue Growth
-9.75%-1.24%
Revenue (Total)
16.63B16.31B15.41B
Revenue (Total) Growth
1.97%5.88%2.81%

EBIT 2

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
Technology & Analytics Solutions Segment Profit
-1.60B1.52B
Technology & Analytics Solutions Segment Profit Growth
-4.80%2.15%
Research & Development Solutions Segment Profit (Pre-FY2026)
-1.87B1.95B
Research & Development Solutions Segment Profit (Pre-FY2026) Growth
--3.85%1.72%
Contract Sales & Medical Solutions Segment Profit
-48.00M47.00M
Contract Sales & Medical Solutions Segment Profit Growth
-2.13%-4.08%
Operating Income (Total)
2.20B2.18B2.20B
Operating Income (Total) Growth
0.83%-0.91%11.38%

Key Performance Indicators

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
Research & Development Solutions Backlog
34.20B34.00B31.10B
Research & Development Solutions Backlog Growth
0.59%9.32%4.71%